NRIX — NURIX THERAPEUTICS INC

Ownership history in BRAIDWELL LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in NURIX THERAPEUTICS INC (NRIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.32% (2025 Q4)
Avg. % of fund
1.32%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 2,183,864 — — 1.32% $41.4M $18.97
% of Fund (quarterly)    NRIX price (monthly, adj. close)

Other funds also holding NRIX

As of 2025 Q4 — sorted by position size

Redmile Group, LLC 3Y 7Y 11.31% GENERAL ATLANTIC, L.P. 3Y 7Y 3.23% Vestal Point Capital, LP 3.02% Commodore Capital LP 3Y 2.87% Elmind Capital, LP 2.58% Kynam Capital Management, LP 3Y 2.39% Deep Track Capital, LP 3Y 2.38% Longaeva Partners L.P. 1.48% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.2% FLAX POND CAPITAL, LLC 1.13%
← Back to BRAIDWELL LP Holdings